The WACC of Oncopeptides AB (ONCO.ST) is 6.2%.
| Range | Selected | |
| Cost of equity | 4.80% - 6.90% | 5.85% |
| Tax rate | 0.10% - 0.20% | 0.15% |
| Cost of debt | 4.00% - 9.90% | 6.95% |
| WACC | 4.6% - 7.8% | 6.2% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.45 | 0.56 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 4.80% | 6.90% |
| Tax rate | 0.10% | 0.20% |
| Debt/Equity ratio | 0.43 | 0.43 |
| Cost of debt | 4.00% | 9.90% |
| After-tax WACC | 4.6% | 7.8% |
| Selected WACC | 6.2% | |